Dividend compounder review

GMED

Globus Medical · NYSE · US

Healthcare · Medical Devices

Chart Factor Intelligence Back to Screener
Score54.50/100
Confidence82.00/100
DecisionInsufficient Data
RatingAvoid
Scoring

Quality breakdown

Dividend Reliability 0.0 / 25 Payment history, cuts, growth, and regularity.
Dividend Sustainability 14.0 / 20 Payout, free cash flow, dividend cover, and debt.
Business Quality 24.0 / 25 Scale, cash generation, growth, margins, and returns.
Valuation Discipline 8.0 / 15 Yield, P/E, and price stretch versus long-term trend.
Long-Term Trend 8.5 / 15 Trend line, long return history, and drawdown control.
Metrics

Dividend and business context

Dividend Years0
Dividend Yield0.00%
Payout Ratio0.0%
Dividend Cut 5YNo
Net Income$537.9M
Free Cash Flow$579.0M
FCF Covers DividendUnknown
Debt / Equity2.45
P/E18.8
Revenue Growth 5Y30.1%
Net Margin18.9%
ROE13.3%
Price vs Trend-8.4%
3Y Return37.6%
5Y Return3.8%
CurrencyUSD
Warnings

Review flags

No usable dividend history found.
Debt to equity is elevated at 2.45.
Dividend diary

Activity record

GMED dividend review warning Warning · Warning

Debt to equity is elevated at 2.45.